21.37
price up icon3.59%   0.74
pre-market  Pre-market:  21.38   0.010   +0.05%
loading
Adma Biologics Inc stock is traded at $21.37, with a volume of 2.20M. It is up +3.59% in the last 24 hours and up +35.42% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$20.63
Open:
$20.63
24h Volume:
2.20M
Relative Volume:
0.46
Market Cap:
$5.01B
Revenue:
$330.24M
Net Income/Loss:
$34.79M
P/E Ratio:
-106.85
EPS:
-0.2
Net Cash Flow:
$66.12M
1W Performance:
-0.47%
1M Performance:
+35.42%
6M Performance:
+127.10%
1Y Performance:
+430.27%
1-Day Range:
Value
$20.47
$21.39
1-Week Range:
Value
$18.90
$21.39
52-Week Range:
Value
$3.60
$23.64

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Name
Adma Biologics Inc
Name
Phone
(201) 478-5552
Name
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Employee
624
Name
Twitter
@AdmaBiologics
Name
Next Earnings Date
2024-12-07
Name
Latest SEC Filings
Name
ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ADMA 21.37 5.01B 330.24M 34.79M 66.12M -0.20
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-19-23 Resumed Raymond James Strong Buy
Oct-13-22 Initiated Mizuho Buy
Nov-11-21 Upgrade Raymond James Outperform → Strong Buy
Nov-09-21 Initiated Cantor Fitzgerald Overweight
Jun-04-19 Initiated Jefferies Buy
Apr-15-19 Reiterated H.C. Wainwright Buy
Feb-07-19 Resumed H.C. Wainwright Buy
Dec-11-17 Reiterated Maxim Group Buy
Nov-14-17 Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17 Upgrade Maxim Group Hold → Buy
Aug-01-16 Downgrade Maxim Group Buy → Hold
Jul-25-16 Reiterated Maxim Group Buy
May-13-15 Reiterated Maxim Group Buy
Dec-08-14 Initiated Oppenheimer Outperform
Dec-01-14 Reiterated Maxim Group Buy
View All

Adma Biologics Inc Stock (ADMA) Latest News

pulisher
Nov 20, 2024

ADMA Biologics drops as auditor resigns - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

New Millennium Group LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire

Nov 18, 2024
pulisher
Nov 18, 2024

Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

Oppenheimer & Co. Inc. Has $1.90 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

GSA Capital Partners LLP Sells 109,045 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - Zacks Investment Research

Nov 15, 2024
pulisher
Nov 15, 2024

Statutory Profit Doesn't Reflect How Good ADMA Biologics' (NASDAQ:ADMA) Earnings Are - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Entropy Technologies LP Purchases Shares of 37,850 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

State of New Jersey Common Pension Fund D Has $2.27 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Janney Montgomery Scott LLC Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

29,143 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by Aigen Investment Management LP - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

ADMA Biologics, Inc. (NASDAQ:ADMA) Stake Raised by Amalgamated Bank - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Principal Financial Group Inc. Has $23.87 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Los Angeles Capital Management LLC Acquires 67,740 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Mesirow Financial Investment Management Inc. Sells 30,105 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Stock Traders Buy Large Volume of ADMA Biologics Call Options (NASDAQ:ADMA) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

Lisanti Capital Growth LLC Takes $4.70 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Predicts Increased Earnings for ADMA Biologics - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

HC Wainwright Issues Positive Forecast for ADMA Biologics (NASDAQ:ADMA) Stock Price - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation - WICZ

Nov 09, 2024
pulisher
Nov 09, 2024

Robeco Institutional Asset Management B.V. Purchases 68,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

New York State Teachers Retirement System Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings call: ADMA Biologics reports robust growth, raises guidance - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

ADMA Biologics stock soars to all-time high of $21.25 By Investing.com - Investing.com South Africa

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics (NASDAQ:ADMA) Stock Price Expected to Rise, Raymond James Analyst Says - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week HighWhat's Next? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics stock soars to all-time high of $21.25 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses - GlobeNewswire

Nov 08, 2024
pulisher
Nov 08, 2024

Adma Biologics: Q3 Earnings Snapshot - CTPost

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Reco - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics, Inc. Revises Earnings Guidance for the Fiscal Year 2024-2025 - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

ADMA Biologics Reports Robust Q3 2024 Growth - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

ADMA Biologics Inc earnings beat by $0.02, revenue topped estimates - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

ADMA Biologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance UK

Nov 07, 2024
pulisher
Nov 07, 2024

ADMA Biologics Inc Reports Q3 2024 Revenue of $119.8 Million, Su - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Did ADMA Biologics (ADMA) Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Investigation - AccessWire

Nov 07, 2024
pulisher
Nov 07, 2024

3 High Growth Tech Stocks Leading The US Market - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

ADMA STOCK ALERT: Why is ADMA Biologics Under Investigation for Securities Fraud? Contact BFA Law if You Lost Money on Your Investment (Nasdaq:ADMA) - AccessWire

Nov 06, 2024
pulisher
Nov 06, 2024

ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know A - GuruFocus.com

Nov 06, 2024

Adma Biologics Inc Stock (ADMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):